Skip to main content
VCbacked
Log inGet Started

Avenzo Therapeutics

San Diego, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

$60.0M raised
Sep 2025
Series B
BiotechnologyHealth CareMedicalOncologyTherapeutics

Top Investors

OrbiMedNew Enterprise AssociatesForesite CapitalSR OneLongwood Fund

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avenzo Therapeutics

How much funding has Avenzo Therapeutics raised?
Avenzo Therapeutics has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
Who are Avenzo Therapeutics's investors?
Avenzo Therapeutics's investors include OrbiMed, New Enterprise Associates, Foresite Capital, SR One, Longwood Fund.
Where is Avenzo Therapeutics headquartered?
Avenzo Therapeutics is headquartered in San Diego, United States.
What does Avenzo Therapeutics do?
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
What stage is Avenzo Therapeutics at?
Avenzo Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Avenzo Therapeutics — Funding & Investors." VCBacked, September 4, 2025, https://www.vcbacked.co/company/avenzo-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2025). Avenzo Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/avenzo-therapeutics
Wikipedia (cite web)
{{cite web |title=Avenzo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avenzo-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K